Probi AB, a Swedish probiotic developer, has appointed Michael Oredsson as chief executive officer, effective in the early autumn of 2007.
Mr Oredsson was previously CEO of Biosignal, an Australian biotech company.
He replaces Per Bengtsson who was let go in November 2006 with severance pay totalling SEK 4.6 million. Rolf Bjerndell, a former Probi board member, has been named Acting CEO until Mr Oredsson assumes office.
Sources:
1) Probi press releases, 21 Nov 2006 and 13 June 2007
2) Probi’s 2006 Annual Report